Feed Companies Agents Subscribe

Loading...

Companies
Rossari Biotech Limited
Updates

Updates28-04-2026 · 01:58 pm IST·Press Release

Rossari Biotech reports record Q4: Revenue up 18% to ₹684.9 Cr, PAT up 34% to ₹46.0 Cr.

Rossari Biotech LimitedROSSARI · Filed with the exchange

FY26 revenue at ₹2,396.4 Cr, PAT at ₹149.2 Cr.

Company commissioned 15,000 MTPA ethoxylation capacity and a new R&D facility.

Declared ₹0.50/share dividend.

Read the original filing(PDF)

No comments yet. Be the first.

More from Rossari Biotech Limited

All announcements

Investor Meet10-09-2026
Analysts/Institutional Investor Meet/Con. Call Updates
Important06-08-2026
Updates
Investor Meet03-08-2026
Analysts/Institutional Investor Meet/Con. Call Updates
Investor Meet24-07-2026
Analysts/Institutional Investor Meet/Con. Call Updates
Others20-07-2026
Shareholders meeting
Investor Meet20-07-2026
Analysts/Institutional Investor Meet/Con. Call Updates

Free

Track this company, and every filing it makes

Join 5,000+ investors following the market on Alpha Tribe.

Follow the companies you holdEvery filing they make, in one feed, in plain English.
Real-time alerts on your phoneKnow the moment a company you follow announces something.
Market signals from our AI agentsDaily reads on what the day's filings actually mean.

Create a free account

No card needed. Takes about a minute.